Platelet-derived Growth Factor (PDGF) BB Acts As a Chemoattractant for Human Malignant Mesothelioma Cells Via PDGF Receptor Beta-integrin Alpha3beta1 Interaction

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 1999 Jan 1

PMID 9872600

Citations 17

Authors

J Klominek

B Baskin

D Hauzenberger

Affiliations

Soon will be listed here.

Abstract

Platelet-derived growth factor BB (PDGF BB) and the PDGF receptor beta are expressed on mesothelioma cells, but their biological function has not yet been defined. In the present study we used Boyden chambers fitted with filters coated with the adhesive matrix proteins fibronectin, laminin, collagen type IV or the nonmatrix adhesive molecule poly-L-lysine (PLL). Mesothelioma cells migrated towards PDGF BB at concentrations ranging from 0.78 to 12.5 ng/ml if matrix proteins were present as adhesive substrates. This migration was integrin dependent since the same cells failed to migrate if the adhesive interactions necessary for migration were provided by molecules other than integrins. Migration of mesothelioma cells on fibronectin, laminin or collagen-type IV in response to PDGF BB was inhibited if the cells were pretreated with blocking antibodies to alpha3beta1 integrin. These findings describe for the first time PDGF BB as a chemoattractant for malignant mesothelioma cells and that collaboration between PDGF receptor beta and integrin alpha3beta1 is necessary for the motile response of these cells to PDGF BB.

Citing Articles

Biological basis for novel mesothelioma therapies.

Obacz J, Yung H, Shamseddin M, Linnane E, Liu X, Azad A Br J Cancer. 2021; 125(8):1039-1055.

PMID: 34226685 PMC: 8505556. DOI: 10.1038/s41416-021-01462-2.

Low-dose photon irradiation induces invasiveness through the SDF-1α/CXCR4 pathway in malignant mesothelioma cells.

Yamauchi Y, Safi S, Orschiedt L, Gardyan A, Brons S, Rieber J Oncotarget. 2017; 8(40):68001-68011.

PMID: 28978091 PMC: 5620231. DOI: 10.18632/oncotarget.19134.

Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905).

Tsao A, Moon J, Wistuba I, Vogelzang N, Kalemkerian G, Redman M J Thorac Oncol. 2017; 12(8):1299-1308.

PMID: 28599887 PMC: 5690479. DOI: 10.1016/j.jtho.2017.05.021.

Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.

Tsao A, Harun N, Fujimoto J, Devito V, Lee J, Kuhn E Ann Diagn Pathol. 2014; 18(3):140-5.

PMID: 24747001 PMC: 4136493. DOI: 10.1016/j.anndiagpath.2014.02.005.

PDGF signaling is required for primitive endoderm cell survival in the inner cell mass of the mouse blastocyst.

Artus J, Kang M, Cohen-Tannoudji M, Hadjantonakis A Stem Cells. 2013; 31(9):1932-41.

PMID: 23733391 PMC: 4063320. DOI: 10.1002/stem.1442.

References

Boutin C, Rey F, Viallat J . Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995; 108(3):754-8. DOI: 10.1378/chest.108.3.754. View

Klominek J, Sumitran Karuppan S, Hauzenberger D . Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins. Int J Cancer. 1997; 72(6):1034-44. DOI: 10.1002/(sici)1097-0215(19970917)72:6<1034::aid-ijc19>3.0.co;2-4. View

Grotendorst G, Seppa H, Kleinman H, Martin G . Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A. 1981; 78(6):3669-72. PMC: 319632. DOI: 10.1073/pnas.78.6.3669. View

Matsui T, Sano K, Tsukamoto T, Ito M, Takaishi T, Nakata H . Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling. J Clin Invest. 1993; 92(3):1153-60. PMC: 288252. DOI: 10.1172/JCI116684. View

Escobedo J, Williams L . A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature. 1988; 335(6185):85-7. DOI: 10.1038/335085a0. View

Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin G . Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol. 1982; 92(2):584-8. PMC: 2112065. DOI: 10.1083/jcb.92.2.584. View

Suzuki Y . Pathology of human malignant mesothelioma. Semin Oncol. 1981; 8(3):268-82. View

Antman K . Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol. 1981; 8(3):313-20. View

Fujii K, Imamura S . Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of alpha 2 beta 1 integrin expression. Exp Cell Res. 1995; 216(1):261-72. DOI: 10.1006/excr.1995.1032. View

10.

Siri A, Carnemolla B, Raffanti S, Castellani P, Balzano E, Zardi L . Fibronectin concentrations in pleural effusions of patients with malignant and non-malignant diseases. Cancer Lett. 1984; 22(1):1-9. DOI: 10.1016/0304-3835(84)90037-5. View

11.

Klominek J, Baskin B, Liu Z, Hauzenberger D . Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer. 1998; 76(2):240-9. DOI: 10.1002/(sici)1097-0215(19980413)76:2<240::aid-ijc12>3.0.co;2-g. View

12.

Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin B, Harris C . Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis. 1990; 11(4):673-81. DOI: 10.1093/carcin/11.4.673. View

13.

Kenworthy P, Dowrick P, McCann B, Tsubouchi H, Arakaki N, Daikuhara Y . The presence of scatter factor in patients with metastatic spread to the pleura. Br J Cancer. 1992; 66(2):243-7. PMC: 1977819. DOI: 10.1038/bjc.1992.251. View

14.

Stoker M, Gherardi E . Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta. 1991; 1072(1):81-102. DOI: 10.1016/0304-419x(91)90008-9. View

15.

Hammacher A, Nister M, Westermark B, Heldin C . A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet-derived growth factor. Eur J Biochem. 1988; 176(1):179-86. DOI: 10.1111/j.1432-1033.1988.tb14266.x. View

16.

Islam K, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith C . Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol. 1994; 152(3):1442-52. View

17.

Stracke M, Kohn E, Aznavoorian S, Wilson L, Salomon D, Krutzsch H . Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Commun. 1988; 153(3):1076-83. DOI: 10.1016/s0006-291x(88)81338-x. View

18.

Ullrich A, Schlessinger J . Signal transduction by receptors with tyrosine kinase activity. Cell. 1990; 61(2):203-12. DOI: 10.1016/0092-8674(90)90801-k. View

19.

Schmitter D, Lauber B, FAGG B, Stahel R . Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int J Cancer. 1992; 51(2):296-301. DOI: 10.1002/ijc.2910510220. View

20.

Forsberg K, Valyi-Nagy I, Heldin C, Herlyn M, Westermark B . Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A. 1993; 90(2):393-7. PMC: 45668. DOI: 10.1073/pnas.90.2.393. View